Company intelligence / Profile preview

Worldwide Biotech

Montclair, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Worldwide Biotech is a biotechnology company focused on the development and commercialization of regenerative medicine and stem cell-based therapies. The company specializes in utilizing adult stem cells to treat a variety of chronic and degenerative conditions, including diabetes, heart disease, and neurological disorders. By leveraging advanced cellular processing techniques, Worldwide Biotech aims to provide innovative treatment options that promote tissue repair and functional recovery. Their business model encompasses research, clinical development, and the establishment of specialized treatment centers to deliver these therapies to patients globally.

Therapeutic areas: EndocrinologyImmunologyNeurologyCardiovascular
Modalities: Stem cell therapyCell therapy
Industry: Biotech

Beyond the preview

Go deeper on Worldwide Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Worldwide Biotech.

Explore the full profile